1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 2:Comparison of mean CSF flow parameters in the hypertension and control groups
Group FFV (mL) FPV (cm/s) RFV (mL) RPV (cm/s) AF (mL/min) NFV (mL) Patients 0.054 (SD, 0.021) 5.338 (SD, 2.024) 0.042 (SD, 0.019) 4.837 (SD, 2.196) 7.480 (SD, 3.221) 0.012 (SD, 0.005) Controls 0.080 (SD, 0.040) 6.197 (SD, 2.394) 0.070 (SD, 0.042) 5.823 (SD, 2.821) 9.824 (SD, 5.435) 0.010 (SD, 0.011) P value <.001 .04 .005 .04 .006 .12